| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $82.1M | +24.5% |
| Cost of Revenue | $33.2M | -32.3% |
| Gross Profit | $48.8M | +189.7% |
| R&D Expense | $37.8M | -32.0% |
| SG&A Expense | $39.8M | -19.8% |
| Operating Income | -$74.4M | +48.9% |
| Pre-tax Income | -$72.5M | +45.7% |
| Income Tax | -$32K | -139.0% |
| Net Income | -$72.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.8M | -34.0% |
| Accounts Receivable | $20.8M | +55.0% |
| Inventory | $70.8M | -3.1% |
| Current Assets | $192.6M | -16.7% |
| Total Assets | $256.1M | -15.8% |
| Current Liabilities | $48.2M | +8.9% |
| Total Liabilities | $87.3M | +3.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.7M | +57.8% |
| Capital Expenditures | $2.7M | -53.4% |
| Investing Cash Flow | -$2.7M | -103.8% |
| Financing Cash Flow | -$1.5M | -755.7% |
| Free Cash Flow | -$44.4M | +57.6% |
| +45.8% |
| EPS (Basic) | -$0.34 | +47.7% |
| EPS (Diluted) | -$0.34 | +47.7% |
| Stockholders' Equity |
| $168.8M |
| -23.3% |